Avraham Ben-Tzvi
CIK 1944721 · last filed 2026-05-26
Avraham Ben-Tzvi is a corporate insider who has filed 9 SEC Form 4 insider transactions across 6 companies since 2023. The most recent filing, for QUCY, was dated May 26, 2026. Current disclosed insider exposure totals $195.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$195.1K
6
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QUCY | Director | 139,141 | $1.09 | $151.7K | $0 | 1 | 2026-05-26 |
| INDP | Director | 25,100 | $1.73 | $43.4K | $0 | 1 | 2026-01-22 |
| Bio Green Med Solution, Inc. (CYCCP) Delisted | Director | — | $5.05 | — | $0 | 1 | 2025-02-28 |
| FiEE, Inc. (MINM) Delisted | Director | 184,364 | $3.61 | $665.6K | $0 | 2 | 2024-10-01 |
| OPGEN INC (OPGN) Delisted | Director | 10,000 | $24.75 | $247.5K | $0 | 1 | 2024-04-15 |
| TITAN PHARMACEUTICALS INC (TTNP) Delisted | Director | 3,312 | $4.61 | $15.3K | $0 | 2 | 2023-10-26 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | QUCY | Grant (A) | +137,141 | $0 | EDGAR |
| 2026-01-22 | INDP | Grant (A) | +25,000 | $0 | EDGAR |
| 2025-10-08 | — | Disp (D) | −3,313 | $0 | |
| 2025-02-28 | Bio Green Med Solution, Inc. (CYCCP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-10-01 | FiEE, Inc. (MINM) Delisted | Grant (A) | +159,364 | $0 | EDGAR |
| 2024-04-15 | OPGEN INC (OPGN) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2024-01-24 | FiEE, Inc. (MINM) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-10-26 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | +16,250 | $0 | EDGAR |
| 2023-07-31 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.